NCT07018427 2025-06-12
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Peking University Cancer Hospital & Institute
Active not recruiting
Clinical Trials
3 trialsNCT06993506 2025-05-29
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06967233 2025-05-13
Multimodal Managements for Metastatic Pancreatic Cancer.
Zhejiang University
Completed